Traduction de «Krabbe's II syndrome » (Anglais → Français) :

Sturge-Weber syndrome | Dimitri-disease | Kalischer's syndrome | Krabbe's II syndrome | Parkes Weber's syndrome | Sturge's syndrome | Sturge's disease | Sturge-Kalischer-Weber syndrome | Sturge-Weber disease | Sturge-Weber-Dimitri syndrome | Weber-Dimitri syndrome | angioma capillare et venosum calcificans | angiomatosis meningo-oculofacialis | congenital neuroectodermal dysplasia | cutaneocerebral angioma | encephalotrigeminal angiomatosis | encephalotrigeminal syndrome | neurocutaneous syndrome

encephalotrigeminal angiomatosis | Sturge-Weber syndrome | Sturge-Weber-Krabbe syndrome

galactocerebrosidase deficiency | galactosylceramide beta-galactosidase deficiency | Galc deficiency | globoid cell leukodystrophy | globoid cell leukoencephalopathy | Krabbe disease | Krabbe's disease | GCL [Abbr.]

Bardet-Biedl syndrome | Biedl's syndrome | Biemond's syndrome | Laurence-Moon-Biedl syndrome | Moon-Bardet-Biedl syndrome

Disease:Fabry(-Anderson) | Gaucher | Krabbe | Niemann-Pick | Farber's syndrome Metachromatic leukodystrophy Sulfatase deficiency

Oto-palato-digital syndrome, type II

Short-rib syndrome, type II

Crigler-Najjar syndrome type II

building safety [ SBS | sick building syndrome ]

AIDS [ acquired immune deficiency syndrome | seropositivity ]

In addition, breeds or strains of animals shall be selected to avoid specific diseases or health problems associated with some breeds or strains used in intensive production, such as porcine stress syndrome, pale-soft-exudative (PSE) syndrome, sudden death, spontaneous abortion and difficult births requiring caesarean operations.

Already in the Scientific Opinion of January 2015, EFSA concluded that olive trees showing symptoms of the bacterium, were generally affected by a multitude of pests and pathogens including Xylella fastidiosa¸ several fungi and Zeuzera pyrina (commonly known as the 'leopard moth'). However, although the specific role of Xylella fastidiosa in the quick "decline syndrome of olive" remains to be fully understood, Xylella fastidiosa has been found in young plants showing signs of the declining syndrome, where no other pathogens where found.

In the following paragraphs, a moderate obstructive sleep apnoea syndrome corresponds to a number of apnoeas and hypopnoeas per hour (Apnoea-Hypopnoea Index) between 15 and 29 and a severe obstructive sleep apnoea syndrome corresponds to an Apnoea-Hypopnoea Index of 30 or more, both associated with excessive daytime sleepiness.

(Return tabled) Question No. 1123 Ms. Kirsty Duncan: With respect to the government’s position on chronic cerebrospinal venous insufficiency (CCSVI): (a) does the government track clinical trials on CCSVI currently being undertaken by other countries and, if yes, what are all clinical trials, identified by phase, currently being undertaken worldwide, (i) which countries are undertaking Phase lll trials; (b) does the government question whether CCSVI exists and, if yes, (i) why does the government not question whether treating CCSVI actually improves quality of life for Canadians with multiple sclerosis (MS); (c) how many cases of " major complications associated with venous angioplasty" have occurred in Canada and, if it is not possible ...[+++]to give this number, why, (i) what are identified complications to CCSVI and, for each complication, how many cases versus the number of procedures undertaken have occurred; (d) what are all procedures that have been performed on veins in Canada, including, procedures for Budd-Chiari syndrome and May-Thurner syndrome; (e) what is the government's position on ballooning veins and why does it consider that ballooning veins even once could be unsafe on fragile veins, even though participants involved in the proposed clinical trial will experience two procedures-one real, one simulated-in a one-year period; (f) is the government consulting with Canadians with MS, if so, (i) provide a list of all CCSVI groups the Minister of Health has met with along with the dates of the meetings, (ii) provide a list of all MS groups the Minister of Health has met with along with the dates of the meetings, (iii) provide the number of Canadians with MS the Minister of Health has met and the dates of all meetings, and if the government is not consulting, (iv) why not; (g) how does inviting the investigators of the seven MS-funded CCSVI studies to participate in the consensus workshop on ultrasound imaging meet CIHR's conflict of interest g ...